FOR IMMEDIATE RELEASE | April 2026 | media@ikongroupinvestments.com
Kynetide Third-Party Research Validation
HOUSTON — Kynetide Peptides announced positive results from independent third-party research validating the efficacy of its proprietary peptide formulations for athletic performance, recovery, and longevity applications.
###
About IKON Group Investments: Global holding company — Houston, TX — ikongroupinvestments.com